Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses Boris MlinarGabriella StoccaRenato Corradetti Translational Neurosciences - Original Article 29 May 2014 Pages: 177 - 185
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis Yoko S. KanekoAkira OtaToshiharu Nagatsu Translational Neurosciences - Original Article 12 June 2014 Pages: 187 - 199
Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice Fernanda Hernandes FigueiraCaroline Queiroz LealRoselei Fachinetto Translational Neurosciences - Original Article 13 June 2014 Pages: 201 - 209
Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer’s disease: a meta-analysis Xue-Bin WangNing-Hua CuiFang Zheng Translational Neurosciences - Original Article 23 May 2014 Pages: 211 - 224
The physiology of the pedunculopontine nucleus: implications for deep brain stimulation E. Garcia-RillJ. HydeE. Petersen Neurology and Preclinical Neurological Studies - Review article 01 June 2014 Pages: 225 - 235
Inter-hemispheric EEG coherence analysis in Parkinson’s disease: Assessing brain activity during emotion processing R. YuvarajM. MurugappanM. Satiyan Neurology and Preclinical Neurological Studies - Original Article 04 June 2014 Pages: 237 - 252
Amplitude-oriented exercise in Parkinson’s disease: a randomized study comparing LSVT-BIG and a short training protocol Georg EbersbachUte GrustAndrea A. Kühn Neurology and Preclinical Neurological Studies - Short communication 29 May 2014 Pages: 253 - 256
Erratum to: Amplitude-oriented exercise in Parkinson’s disease: a randomized study comparing LSVT-BIG and a short training protocol Georg EbersbachUte GrustAndrea A. Kühn Erratum 03 July 2014 Pages: 257 - 257
Deuterium-substituted l-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson’s disease: comparison with the effects produced by l-DOPA and an MAO-B inhibitor Torun MalmlöfKristin FeltmannBjörn Schilström Neurology and Preclinical Neurological Studies - Original Article 07 June 2014 Pages: 259 - 272
Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study Z. MatejčíkováJ. MarešP. Kaňovský Neurology and Preclinical Neurological Studies - Original Article 04 June 2014 Pages: 273 - 277
Serotonergic transmission after spinal cord injury Raffaele NardoneYvonne HöllerEugen Trinka Neurology and Preclinical Neurological Studies - Review Article 28 May 2014 Pages: 279 - 295
Botulinum toxin therapy of cervical dystonia: duration of therapeutic effects Dirk DresslerPawel TacikFereshte Adib Saberi Neurology and Preclinical Neurological Studies - Original Article 23 July 2014 Pages: 297 - 300
Influence of comorbid alcohol use disorder on treatment response of depressive patients Eri HashimotoMasaya TayamaToshikazu Saito Psychiatry and Preclinical Psychiatric Studies - Original Article 14 June 2014 Pages: 301 - 306
Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis Cai-Yun HuZhen-Zhong QianYe-Huan Sun Psychiatry and Preclinical Psychiatric Studies - Original Article 18 June 2014 Pages: 307 - 320
Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study Emil F. CoccaroRoyce LeeMary Coussons-Read Psychiatry and Preclinical Psychiatric Studies - Original Article 24 July 2014 Pages: 321 - 326
Safety aspects of incobotulinumtoxinA high-dose therapy Dirk DresslerFereshte Adib SaberiChristoph Schrader Psychiatry and Preclinical Psychiatric Studies - Original Article 17 July 2014 Pages: 327 - 333